Status:
COMPLETED
STUDY OF GLUCOSE IN DIALYSIS WATER WITH REGARD TO BLOOD PRESSURE AND QUALITY OF LIFE
Lead Sponsor:
Regional Hospital Holstebro
Conditions:
Hemodialysis
Eligibility:
All Genders
18+ years
Phase:
PHASE4
Brief Summary
We wanted to test the hypotheses that blood pressure level was lower, that the variability of blood pressure and blood glucose was reduced, and that quality of life was improved when glucose was added...
Detailed Description
The purpose of the study was to determine the effect of glucose added to the dialysis fluid on 1.blood pressure and variation in blood pressure, 2.blood glucose and variation in blood glucose, and 3.q...
Eligibility Criteria
Inclusion
- age more than 18 years, both men and women, and hemodialysis treatment for more than three months
Exclusion
- treatment with hemodiafiltration, change to another dialysis modality, renal transplantation, alcohol abuse defined as more than 21 drinks a week for men and more than 14 drinks a week for women, and unwillingness to participate.
Key Trial Info
Start Date :
May 1 2003
Trial Type :
INTERVENTIONAL
End Date :
May 1 2003
Estimated Enrollment :
55 Patients enrolled
Trial Details
Trial ID
NCT00278057
Start Date
May 1 2003
End Date
May 1 2003
Last Update
January 18 2006
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Department of Medicine, Holstebro Hospital
Holstebro, Denmark, 7500